Home / Resource Library / R-CEOP as first-line treatment for anthracycline-ineligible patients with diffuse large B-cell lymphoma

R-CEOP as first-line treatment for anthracycline-ineligible patients with diffuse large B-cell lymphoma

Results of a study investigating etoposide based chemoimmunotherapy for first line treatment of DLBCL.